Last updated: April 14, 2022
Sponsor: Affiliated Hospital to Academy of Military Medical Sciences
Overall Status: Active - Recruiting
Phase
N/A
Condition
Digestive System Neoplasms
Gall Bladder Cancer
Primary Biliary Cholangitis
Treatment
N/AClinical Study ID
NCT05320497
Transparent Cap
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- The indications for ERCP.
- Written informed consent
Exclusion
Exclusion Criteria:
- Underlying bleeding disorder
- The platelet count less than 50×10^9/L
- Serious cardio-pulmonary, hepatic or renal disease
- Intolerance to ERCP
- Other high-risk conditions or disease (such as massive ascites, etc.)
- Pregnancy
Study Design
Total Participants: 10
Study Start date:
April 14, 2022
Estimated Completion Date:
July 30, 2022
Study Description
Connect with a study center
The Fifth Medical Center of Chinese PLA General Hosptial
Beijing, Beijing 100039
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.